Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 43 for “"Chlorambucil"”.
-
Synergistic Interactions of Chlorambucil, DHA, and Trail in Jurkat and H460 Human Cancer Cells
… tissue. In this study, the alkylating agent chlorambucil (CLB) was combined with DHA and TRAIL in order to assess their ability to induce apoptosis synergistically in Jurkat human T-cell leukemia and NCI-H460 human non-small cell lung cancer cell lines. Dose response curves were created by …
-
Die therapieabhängige Kinetik der Neubesiedlung des T-Zellkompartiments im peripheren Blut von Patienten mit rezidivierender chronischer lymphatischer Leukämie
… Hierzu wurden Patienten der Therapiearme (Chlorambucil/Obinutuzumab vs. Venetoclax/Obinutuzumab) anhand prätherapeutischer Parameter und ihres Ansprechens kategorisiert und anschließend untersucht. CLL-Patienten zeigten ein deutlich reduziertes T-Zellrepertoire mit oligoklonalen …
-
Development and evaluation of drug-antibody conjugates for the treatment of human myelogenous leukemia
… Conjugates of methotrexate, daunomycin and chlorambucil, covalently bound either directly or through a dextran bridge to a minimum amount of anti K-562 Ig, were tested for their capacity to suppress tumor development in nude mice. The effect of drug-antibody conjugates was compared with that …
-
Κυτταρογενετικές και βιοχημικές μελέτες αντικαρκινικών και εν δυνάμει αντικαρκινικών φαρμάκων
… modified steroidal esters with alkylating agent chlorambucil or active metabolites of chlorambucil or nitrozourea. Firstly, the induction of Sister Chromatid Exchanges (SCEs) as a very sensitive indicator of cytotoxic damage and the decrease of Proliferation Rate Index (PRI) as a valuable marker …
-
Development of Lipid Nanodisc Technology for the Formulation of Poorly Water Soluble Drugs
… release rate. In the case of amiodarone and chlorambucil incorporation, a decrease in membrane thickness was seen to be correlated with the efficiency of drug loading within the POPC bilayer. In addition, the lipid composition within nanodiscs was varied in order to investigate its effect on …
-
Cancer Chemotherapy: Use of Low Density Lipoproteins As Targeting Vehicles for Treatment
… are employed for incorporating adriamycin, chlorambucil and daunomycin into LDL and the drug-LDL complexes so formed show enhanced cytotoxicity in vitro and in vivo. It is likely that LDL will be a useful targeting vehicle for anticancer agents if the level of drug incorporation can be …
-
Synthesis and Pharmacological Evaluation of Nitrogen Oxide Releasing Prodrugs
… lines, irrespective of estrogen dependence.iv. Chlorambucil analogue of PABA/NOChlorambucil, an alkylating agent is used in leukemia treatment. Tumor cells resistant to alkylating agents often have increased glutathione levels and increased activity of glutathione-S-transferase (GST). PABA/NO is …
-
The anti-cancer potential of polyphenols in the treatment of leukaemia.
… (etoposide, doxorubicin, cyclophosphamide, chlorambucil, cisplatin, methotrexate, 6-mercaptopurine, 5-fluorouracil and imatinib). For this polyphenol and chemotherapy combination work four leukaemia cells lines were used: the two most sensitive (JURKAT and CCRFM-CEM) and two most resistant …
-
The Role of Mitochondrial DNA Replication Fidelity in Toxicity Initiated by Drugs that Impair Mitochondrial Function
… (MPP) was used to target the alkylating agent chlorambucil (Cbl) specifically to mitochondria. Mitochondria-targeted Cbl (mt-Cbl) caused bioenergetic differences between Polgm/m and wild type MEFs, but was not differentially toxic at the level of cell viability. Increasing mitochondrial …
-
Proteineria and Progression in Glomerular Diseases.
… is more effective and less toxic than chlorambucil.
-
The chemotherapeutic consequences of tumor pH in breast carcinoma model systems
… accumulation of mitoxantrone, doxorubicin and chlorambucil remained constant even in drug resistant cell lines such as the MCF-7D40 and MCF-7mitox cell lines. In an MCF-7 tumor/SCID mouse model the in vivo biodistribution of doxorubicin in alkalotic mice was evaluated. No significant difference …
-
Structural activity and mechanistic studies on glycosylated antitumor ether lipids (GAELs)
… of clinical anticancer drugs like cisplatin, chlorambucil and the experimental anti-CSCs agent salinomycin. These analogs are potential drug candidates for clinical development as new anticancer agents. Also, the use of L-sugar to resist metabolic degradation opens new opportunities for …
-
Design, synthesis and antitumor properties of glycosylated antitumor ether lipid (GAEL) – hybrids
… activities of different analogs of GAEL–chlorambucil hybrids and different triamino analogs. In all, eleven GAEL analogs were synthesized. Their activities, as well as that of reference compounds, were assessed against breast (JIMT1, MDA-MB-231, BT474), pancreas (MiaPaCa2) and prostate …
-
Harnessing Mitochondria-penetrating Peptides for the Organellar Delivery of Small Molecule Drugs
… harnessed to re-route an anti-leukemia agent, chlorambucil (Cbl), from the nucleus to mitochondria. This DNA alkylating agent was selected for its rapid kinetics and facile conjugation to an MPP. In addition, because mitochondria possess their own genome, the target of this drug would also be …
-
Synthesis and NMR Spectroscopy of Tripeptide Derived Biomolecules for Site Specific Radiopharmaceuticals
… to the alkylating agen chlorambucil. The product of the 10 step synthesis (30% overll yield) was characterized by several high resolution NMR techniques.</p>
-
Development and Evaluation of Nanoparticulate Drug Delivery Systems for Anticancer Drugs
… nanoparticulate drug delivery systems for chlorambucil (CHL) and asulacrine (ASL). CHL is a DNA alkylating agent. In an attempt to alter the pharmacokinetics (short half-life, rapid clearance and high volume of distribution) and improve the anticancer activity, CHL was incorporated into a …
Page 1 of 3